RHEACELL GmbH & Co. KG
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 2003-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.rheacell.com
Clinical Trials
30
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (30 trials with phase data)• Click on a phase to view related trials
CLINICAL STUDY TO TEST STEM CELLS FOR THE TREATMENT OF LONG-TERM, NON-HEALING VENOUS LEG ULCERS
- Conditions
- chronic venous ulcers (CVU)
- First Posted Date
- 2024-07-05
- Last Posted Date
- 2025-10-01
- Lead Sponsor
- Rheacell GmbH & Co. KG
- Target Recruit Count
- 230
- Registration Number
- 2024-512720-11-00
- Locations
- 🇬🇧
RHEACELL Clinical Trial Site, Multiple Locations, United Kingdom
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)
- First Posted Date
- 2023-05-01
- Last Posted Date
- 2023-10-30
- Lead Sponsor
- RHEACELL GmbH & Co. KG
- Target Recruit Count
- 74
- Registration Number
- NCT05838092
- Locations
- 🇺🇸
Masonic Cancer Center and Medical Center Minneapolis, Minneapolis, Minnesota, United States
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)
- First Posted Date
- 2022-07-19
- Last Posted Date
- 2023-02-24
- Lead Sponsor
- RHEACELL GmbH & Co. KG
- Target Recruit Count
- 74
- Registration Number
- NCT05464381
- Locations
- 🇦🇹
EB-Haus Austria; Salzburger Landeskliniken (SALK), Salzburg, Austria
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)
- Conditions
- Skin Ulcer Venous Stasis Chronic
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-07-21
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- RHEACELL GmbH & Co. KG
- Target Recruit Count
- 200
- Registration Number
- NCT04971161
- Locations
- 🇩🇪
MVZ Gefäßzentrum Aachen am Marienhospital Aachen GmbH, Aachen, Germany
🇩🇪Universitätsklinikum Augsburg, Klinik für Dermatologie und Allergologie, Campus Süd, Augsburg, Germany
🇩🇪Fachklinik Bad Bentheim, Dermatologische Ambulanz, Bad Bentheim, Germany
Allogeneic ABCB5-positive Stem Cells for Treatment of Acute-on-Chronic Liver Failure
- Conditions
- Acute-On-Chronic Liver Failure
- First Posted Date
- 2019-03-01
- Last Posted Date
- 2021-11-17
- Lead Sponsor
- RHEACELL GmbH & Co. KG
- Target Recruit Count
- 5
- Registration Number
- NCT03860155
- Locations
- 🇩🇪
Universitätsklinikum Carl-Gustav-Carus an der TU Dresden, Medizinische Klinik I, Dresden, Germany
🇩🇪Universitätsklinikum Essen, Klinik für Gastroenterologie und Hepatologie, Medizinisches Forschungszentrum, Essen, Germany
🇩🇪Universitätsklinikum Frankfurt, Medizinische Klinik 1, Sektion Translationale Hepatologie, Frankfurt, Germany
- Prev
- 1
- 2
- 3
- Next